Approval · Notice of Compliance 37699 · 2026
PEXEGRA: Notice of Compliance 37699
Issued June 12, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37699
- Date
- June 12, 2026
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of an alternative manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEXEGRA | Not yet assigned | — |
Medicinal ingredients
- PEGFILGRASTIM 10 MG per ML